Virtual Practice
Recommend

Dr. Vamsidhar Velcheti

Internal Medicine - Oncology
Cleveland, OH
About
Insights
Network
Welcome!
About me
I specialize in
Internal Medicine - Oncology
I have been in practice
6 years
I speak
English
I'm known for
Doctor
Votes
Member
Votes
Cancer
--
Locally
34
Lung cancer
1st
Locally
24
Lung nodule
1st
Locally
3
Recommend me
My answers and insights have
Helped 133,442 people
Received 189 doctor agrees
Received 67 thanks
Here are kind words from others
Very helpful and caring answers.
Recommend me
Office hours
Mon 8:00am - 5:00pm
Tue 8:00am - 5:00pm
Fri 8:00am - 5:00pm
I was educated and trained at
Medical / Graduate School
University of Pune, Armed Forces Medical College, India
Fellowships
Medical Oncology YALE-NEW HAVEN HOSPITAL
Hematology YALE-NEW HAVEN HOSPITAL
I've won the following awards
ASCO Merit Award, American Society of Clinical Oncology
ASCO Young Investigator Award 2012
HealthTap Founding Doctor
HealthTap Honor
I've published
High SOX2 levels predict better outcome in non-small cell lung carcinomas.
PloS one, 8, e61427 (2013)
V Velcheti, K Schalper, X Yao, H Cheng, M Kocoglu, K Dhodapkar, Y Deng, S Gettinger, D L Rimm
Sarcomatoid lung carcinomas show high levels of programmed death ligand-1 (PD-L1).
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 8, 803-5 (2013)
V Velcheti, D L Rimm, K A Schalper
Management of patients with advanced non-small cell lung cancer: role of gefitinib.
Biologics : targets & therapy, 4, 83-90 (2010)
V Velcheti, D Morgensztern, R Govindan
Here are some of my top insights